This study evaluates a digital art activity to enhance self-disclosure and the detection of psycho-social distress in adult cancer patients. Psychological or psycho-social distress (a combination of hopelessness, anxiety, fear and depression) is common in cancer patients. Trauma and/or shame related to the location of the cancer in the body can also change a patient’s ability to express how and what they feel. This may affect the ability to be self-aware and/or express feelings or perspective. Poor or incomplete communication between a patient and the medical team may impact the quality of care and how well symptoms are managed. An art-based expression tool could provide an interesting addition to the tests that are already being used to measure these feelings or conditions. The use of art may help patients feel less defensive, which may help them share more feelings and be able to express the experience of living with cancer.
Additional locations may be listed on ClinicalTrials.gov for NCT06127121.
Locations matching your search criteria
United States
Texas
Houston
M D Anderson Cancer CenterStatus: Active
Contact: Carlos Roldan
Phone: 713-563-7402
PRIMARY OBJECTIVE:
I. To evaluate how engaging in a digital art activity might potentially cause changes in symptom reporting, based on pre/post self-reporting on the Edmonton Symptom Assessment System (ESAS) at time T3.
SECONDARY OBJECTIVES:
I. To evaluate the changes in symptom reporting, based on pre/post self-reporting on ESAS at different times of the study (T1, T2).
II. To evaluate how a specific creative art making activity (T3), compared to an active control condition (T2; music listening) may or may not impact reporting ESAS.
III. To monitor potential changes in distress disclosure, based on the self-report scoring on the Distress Disclosure Index score at T0, T2 and T3.
OUTLINE: This is an observational study.
Patients use a digital art tool to complete a digital art activity over 2 days (visits T1 and T3) on study. Patients also complete a music listening activity during visit T2.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationM D Anderson Cancer Center
Principal InvestigatorCarlos Roldan
